💊 Strength Under the Surface in XPH — Eyes on Jazz 🎷

We’re seeing continued strength building beneath the surface in the SPDR S&P Pharmaceuticals ETF (XPH). This week, 91% of weekly scores are advancing 📈, a powerful sign of underlying momentum. Yet interestingly, only 41% of the scores are currently positive ⚠️—suggesting we’re still in the early phase of a broader shift.

This kind of setup—a strong surge in breadth without full price confirmation—often precedes more decisive moves in the sector. In other words, the foundation is being laid, but the breakout may still be ahead 🔍.

One name of particular interest is Jazz Pharmaceuticals (JAZZ). It's flashing on our radar as a pending High Conviction signal 🚨 this week. We’ll be watching closely to see if that confirmation comes through—it could be an early mover in a sector poised for broader rotation.

Stay tuned for updates! 👀